Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials

Fig. 4

Forest plot comparing the adverse drug reactions between TAPT and DAPT in T2DM patients after intracoronary stenting. More adverse effects are associated with cilostazol use in this TAPT compared to DAPT in these T2DM patients

Back to article page